Maris Kamalu

Maris Kamalu

Auto-generated profile, based on publicly available information

Maris Kamalu

Department of Molecular, Cell and Developmental Biology, University of California at Los Angeles, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Nature Plants
Verified
Journal Article
Open access
PDF file
TWTrevor Weiss
Trevor Weiss
MKMaris Kamalu
Maris Kamalu
HSHonglue Shi
Honglue Shi
ZLZheng Li
Zheng Li
JAJasmine Amerasekera
Jasmine Amerasekera
Steven E. JacobsenSteven E. Jacobsen
Steven E. Jacobsen
Genome editing is transforming plant biology by enabling precise DNA modifications. However, delivery of editing systems into plants remains challenging, often requiring slow, genotype-specific methods such as tissue culture or transformation 1 . Plant viruses, which naturally infect and spread to most tissues, present a promising delivery system for editing reagents. However, many viruses have limited cargo capacities, restricting their ability to carry large CRISPR-Cas systems. Here we engineered tobacco rattle virus (TRV) to carry the compact RNA-guided TnpB enzyme ISYmu1 and its guide RNA. This innovation allowed transgene-free editing of Arabidopsis thaliana in a single step, with edits inherited in the subsequent generation. By overcoming traditional reagent delivery barriers, this approach offers a novel platform for genome editing, which can greatly accelerate plant biotechnology and basic research.

16 July 2026 in Science
Verified
Journal Article
Closed access
PSPetr Skopintsev
Petr Skopintsev
IEIsabel Esain-Garcia
Isabel Esain-Garcia
EDEvan C. DeTurk
Evan C. DeTurk
PYPeter H. Yoon
Peter H. Yoon
ZZZehan Zhou
Zehan Zhou
JDJennifer A. Doudna
Jennifer A. Doudna
The design of RNA-guided nucleases with properties not limited by evolution can expand programmable genome-editing capabilities. However, generating diverse multidomain proteins with robust enzymatic properties remains challenging. Here, we use a protein design strategy that couples a structure-guided inverse-folding model with evolution-informed residue constraints to generate active, divergent variants of TnpB, a minimal CRISPR-Cas12–like nuclease, termed SynTnpBs. High-throughput screening of artificial intelligence–generated variants yielded editors that retained or exceeded wild-type activity in bacterial, plant, and human cells. Cryo–electron microscopy–based structure determination of the most divergent variant revealed stabilizing contacts in the RNA–DNA interfaces across conformations, demonstrating the design potential of this approach. Together, these results establish a strategy for creating non-natural RNA-guided nucleases and conformationally active nucleic acid binders, enlarging the designable protein space.

8 December 2025 in bioRxiv
Verified
Preprint
Open access
PSPetr Skopintsev
Petr Skopintsev
IEIsabel Esain-Garcia
Isabel Esain-Garcia
EDEvan C. DeTurk
Evan C. DeTurk
PYPeter H. Yoon
Peter H. Yoon
ZZZehan Zhou
Zehan Zhou
JDJennifer A. Doudna
Jennifer A. Doudna
The design of RNA-guided nucleases with properties not limited by evolution can expand programmable genome editing capabilities. However, generating diverse multi-domain proteins with robust enzymatic properties remains challenging. Here we use an artificial intelligence-driven strategy that couples structure-guided inverse protein folding with evolution-informed residue constraints to generate active, divergent variants of TnpB, a minimal CRISPR-Cas12-like nuclease. High-throughput functional screening of AI-generated variants yielded editors that retained or exceeded wild-type activity in bacterial, plant and human cells. Cryo-EM-based structure determination of the most divergent active variant revealed new stabilizing contacts in the RNA/DNA interfaces across conformational states, demonstrating the design potential of this approach. Together these results establish a strategy for creating non-natural RNA-guided nucleases and conformationally active nucleic acid binders, enlarging the designable protein space.